Researchers compared outcomes associated with conventional excision vs Mohs micrographic surgery among patients with hand and foot melanoma.

Two major contributors to reduced health-related quality of life (HRQoL) in patients with chronic lymphocytic leukemia (CLL) and lymphoma are muscle weakness and fatigue, according to a study ...

Prevalence of dyspnea is high among advanced cancer survivors, with several associated factors, stressing a need for early detection and comprehensive management strategies.

Patients with initial nodal metastases and breast pCR on vacuum-assisted biopsy who underwent targeted axillary dissection had axillary pCR.

The findings suggest that enfortumab vedotin, especially combined with pembrolizumab, offers promising beneficial outcomes in metastatic urothelial carcinoma treatment,” researchers wrote.

The researchers called for further study to understand the mechanism of the relationship between obesity and ICI outcomes.

Pediatric patients with ALL experience, on average, about 15 different symptoms in their chemotherapy journey.

Repeat biopsies in patients with TNBC may detect changes in HER2 status and allow more patients to gain access to T-DXd, data suggest.

A longitudinal assessment of patient-reported outcomes demonstrated that pexidartinib (Turalio) continues to offer clinically meaningful symptom relief with extended use in patients with tenosynovial ...

Enhertu (fam-trastuzumab deruxtecan-nxki) is currently indicated as a second-line therapy for HER2-positive metastatic breast cancer.

Patients who continued to receive pembrolizumab-based therapy after disease progression had longer overall survival than patients who stopped receiving pembrolizumab-based therapy.

Adherence to American Cancer Society guidelines linked to lower mortality in nonsmoking survivors of obesity-related cancer.